HON
70
5
IPG
49
-5
PSX
44
2
APA
19
2
CAG
31
-3
WAT
61
-3
NTRS
59
2
LB
49
-33
SYK
66
2
HCA
53
2
GT
64
-3
ADSK
75
3
KMB
28
-2
MMC
61
-3
SJM
17
-4
SLB
57
4
COST
63
-4
BA
50
-2
AZO
58
5
NUE
62
-2
HON
70
5
IPG
49
-5
PSX
44
2
APA
19
2
CAG
31
-3
WAT
61
-3
NTRS
59
2
LB
49
-33
SYK
66
2
HCA
53
2
GT
64
-3
ADSK
75
3
KMB
28
-2
MMC
61
-3
SJM
17
-4
SLB
57
4
COST
63
-4
BA
50
-2
AZO
58
5
NUE
62
-2
Financhill
Back

Eton Pharmaceuticals 10K Form

Buy
71

ETON
Eton Pharmaceuticals

Last Price:
9.13
Seasonality Move:
9.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ETON News And Ratings

See the #1 stock for the next 7 days that we like better than ETON

ETON Financial Statistics

Sales & Book Value

Annual Sales: $31.64M
Cash Flow: $1.26M
Price / Cash Flow: 0
Annual Sales: $0.52
Price / Book: 18.69

Profitability

EPS (TTM): -0.26000
Net Income (TTM): $-6.69M
Gross Margin: $21.06M
Return on Equity: -42.84%
Return on Assets: -21.32%

Eton Pharmaceuticals Earnings Forecast

Key Eton Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for ETON is 66.56%.
  • The Selling, General & Administrative Expenses for ETON have been equal to 59.83% of Gross Profit Margin.
  • The Research & Development expenses have been 10.50% of Revenue.
  • The Net Earning history of ETON is -2.96% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Eton Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ETON
CUSIP: 29772L
Website: etonpharma.com

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 1.4
Quick Ratio: 1.24

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 18.38

ETON Technical Analysis vs Fundamental Analysis

Buy
71
Eton Pharmaceuticals (ETON) is a Buy

Is Eton Pharmaceuticals a Buy or a Sell?